LOGIN  |  REGISTER
Viking Therapeutics

Recent Insider Transactions - Viridian Therapeutics (NASDAQ: VRDN)

Follow NASDAQ:VRDN Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ VRDN Viridian Therapeutics
CAIN CHRISTOPHER W. / director
07/01/2025
Buy
$14.47
21,000
$304K
21,000
NASDAQ VRDN Viridian Therapeutics
Kiselak Tomas / director
07/01/2025
Buy
$14.47
21,000
$304K
21,000
NASDAQ VRDN Viridian Therapeutics
Morris Arlene / director
07/01/2025
Buy
$14.47
21,000
$304K
21,000
NASDAQ VRDN Viridian Therapeutics
Ajer Jeffrey Robert / director
07/01/2025
Buy
$14.47
21,000
$304K
21,000
NASDAQ VRDN Viridian Therapeutics
Gheuens Sarah / director
07/01/2025
Buy
$14.47
21,000
$304K
21,000
NASDAQ VRDN Viridian Therapeutics
Moses Jennifer K. / director
07/01/2025
Buy
$14.47
21,000
$304K
21,000
NASDAQ VRDN Viridian Therapeutics
Fairmount Funds Management LLC / director, 10 percent owner:
06/10/2025
Buy
$12.31
12,500
$154K
3.46M
NASDAQ VRDN Viridian Therapeutics
Fairmount Funds Management LLC / director, 10 percent owner:
06/09/2025
Buy
$7.80
1,600
$12K
3.45M
NASDAQ VRDN Viridian Therapeutics
Fairmount Funds Management LLC / director, 10 percent owner:
06/09/2025
Sell
$7.80
1,600
$12K
0
NASDAQ VRDN Viridian Therapeutics
Fairmount Funds Management LLC / director, 10 percent owner:
06/10/2025
Sell
$12.31
12,500
$154K
0

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous